FL_genes.md
... ...
@@ -11,36 +11,27 @@ link-citations: true
11 11
12 12
## Tier 1 FL genes
13 13
14
-### *66 total*
14
+### *49 total*
15 15
16 16
|Gene|Summary| First FL study | Other entities | QC result |
17 17
|:-:|:-:|:-:|:-|:-|
18
-|[ACTB](ACTB)|Tier 1 GE||[@lohrDiscoveryPrioritizationSomatic2012a; @wienandGenomicAnalysesFlowsorted2019b]||
19 18
|[ARID1A](ARID1A)|Tier 1 GE[@krysiakRecurrentSomaticMutations2017b], FE[@barisicARID1AOrchestratesSWI2024]|[Krysiak et al](papers/krysiakRecurrentSomaticMutations2017b)|[@loveGeneticLandscapeMutations2012; @rossiCodingGenomeSplenic2012c; @wienandGenomicAnalysesFlowsorted2019b; @zhangGeneticHeterogeneityDiffuse2013]||
20 19
|[ATP6AP1](ATP6AP1)|Tier 1 GE[@okosunRecurrentMTORC1activatingRRAGC2016a]|[Okosun et al](papers/okosunRecurrentMTORC1activatingRRAGC2016a)|||
21 20
|[ATP6V1B2](ATP6V1B2)|Tier 1 GE[@okosunRecurrentMTORC1activatingRRAGC2016a]|[Okosun et al](papers/okosunRecurrentMTORC1activatingRRAGC2016a)|||
22 21
|[B2M](B2M)|Tier 1 GE[@morinFrequentMutationHistonemodifying2011], FE[@challa-malladiCombinedGeneticInactivationa]|[Morin et al](papers/morinFrequentMutationHistonemodifying2011)|[@pararajalingamCodingNoncodingDrivers2020; @reichelFlowSortingExome2015a]||
23 22
|[BCL2](BCL2)|Tier 1 GE[@morinFrequentMutationHistonemodifying2011], FE[@balSuperenhancerHypermutationAlters2022]|[Morin et al](papers/morinFrequentMutationHistonemodifying2011)|[@burkhardtClinicalRelevanceMolecular2022b; @sarkozyMutationalLandscapeGray2021a; @tanakaFrequentIncidenceSomatic1992]||
24
-|[BCL6](BCL6)|Tier 1 GE, FE[@balSuperenhancerHypermutationAlters2022]||[@loveGeneticLandscapeMutations2012; @morinFrequentMutationHistonemodifying2011]||
25 23
|[BCL7A](BCL7A)|Tier 1 GE[@krysiakRecurrentSomaticMutations2017b], FE[@balinas-gaviraFrequentMutationsAminoterminal2020b]|[Krysiak et al](papers/krysiakRecurrentSomaticMutations2017b)|[@grandeGenomewideDiscoverySomatic2019; @morinFrequentMutationHistonemodifying2011; @reichelFlowSortingExome2015a]||
26
-|[BIRC6](BIRC6)|Tier 1 GE||[@reddyGeneticFunctionalDrivers2017; @sarkozyMutationalLandscapeGray2021a]||
27
-|[BTG1](BTG1)|Tier 1 GE, FE[@mlynarczykBTG1MutationYields2023b]||[@burkhardtClinicalRelevanceMolecular2022b; @morinFrequentMutationHistonemodifying2011; @sarkozyMutationalLandscapeGray2021a]||
28
-|[BTG2](BTG2)|Tier 1 GE[@morinFrequentMutationHistonemodifying2011], CE[@guoMutationBTG2Gene2022b]|[Morin et al](papers/morinFrequentMutationHistonemodifying2011)|[@loveGeneticLandscapeMutations2012]||
29 24
|[BTK](BTK)|Tier 1 GE[@krysiakRecurrentSomaticMutations2017b]|[Krysiak et al](papers/krysiakRecurrentSomaticMutations2017b)|[@albuquerqueEnhancingKnowledgeDiscovery2017a]||
30 25
|[CARD11](CARD11)|Tier 1 GE[@morinFrequentMutationHistonemodifying2011], FE[@lenzOncogenicCARD11Mutations2008], CE[@zhaoExpressionPrognosticValue2016]|[Morin et al](papers/morinFrequentMutationHistonemodifying2011)|[@lenzOncogenicCARD11Mutations2008; @wuGeneticHeterogeneityPrimary2016; @yanBCRTLRSignaling2012a]||
31 26
|[CCND3](CCND3)|Tier 1 GE[@morinFrequentMutationHistonemodifying2011], FE[@schmitzBurkittLymphomaPathogenesis2012]|[Morin et al](papers/morinFrequentMutationHistonemodifying2011)|[@deschGenotypingCirculatingTumor2020; @jalladesExomeSequencingIdentifies2017; @richterRecurrentMutationID32012a]||
32 27
|[CD83](CD83)|Tier 1 GE[@russler-germainMutationsAssociatedProgression2023b]|[Russler et al](papers/russler-germainMutationsAssociatedProgression2023b)|[@dunsCharacterizationDLBCLPMBL2021b; @morinMutationalStructuralAnalysis2013; @paneaWholeGenomeLandscape2019]||
33 28
|[CREBBP](CREBBP)|Tier 1 GE[@pasqualucciInactivatingMutationsAcetyltransferase2011a], FE[@pasqualucciInactivatingMutationsAcetyltransferase2011a]|[Pasqualucci et al](papers/pasqualucciInactivatingMutationsAcetyltransferase2011a)|[@dunsCharacterizationDLBCLPMBL2021b; @loveGeneticLandscapeMutations2012; @parryWholeExomeSequencing2013]||
34 29
|[CTSS](CTSS)|Tier 1 GE[@barariaCathepsinAlterationsInduce2020c]|[Bararia et al](papers/barariaCathepsinAlterationsInduce2020c)|||
35
-|[DTX1](DTX1)|Tier 1 GE, FE[@demirandaExomeSequencingReveals2014], CE[@merirantaDeltex1MutationsPredict2017b]||[@gomezUltraDeepSequencingReveals2023; @loveGeneticLandscapeMutations2012; @rossiCodingGenomeSplenic2012c; @zhangGeneticHeterogeneityDiffuse2013]||
36
-|[EBF1](EBF1)|Tier 1 GE||[@bohleRoleEarlyBcell2013; @reichelFlowSortingExome2015a; @thomasGeneticSubgroupsInform2023]||
37 30
|[EEF1A1](EEF1A1)|Tier 1 GE[@hubschmannMutationalMechanismsShaping2021b], CE[@gongExpressionClinicalValue2021]|[Hubschmann et al](papers/hubschmannMutationalMechanismsShaping2021b)|[@reichelFlowSortingExome2015a]||
38 31
|[EP300](EP300)|Tier 1 GE[@pasqualucciInactivatingMutationsAcetyltransferase2011a], FE[@pasqualucciInactivatingMutationsAcetyltransferase2011a]|[Pasqualucci et al](papers/pasqualucciInactivatingMutationsAcetyltransferase2011a)|[@rossiCodingGenomeSplenic2012c]||
39 32
|[EZH2](EZH2)|Tier 1 GE[@morinSomaticMutationsAltering2010a], FE[@yapSomaticMutationsEZH22011b]|[Morin et al](papers/morinSomaticMutationsAltering2010a)|[@loveGeneticLandscapeMutations2012; @mottokIntegrativeGenomicAnalysis2019b]||
40
-|[FAS](FAS)|Tier 1 GE, FE[@seebergerLossFasCD952001]||[@schollMutationsRegionFAS2007; @spinaGeneticsNodalMarginal2016b]||
41 33
|[FOXO1](FOXO1)|Tier 1 GE[@morinFrequentMutationHistonemodifying2011], FE[@trinhAnalysisFOXO1Mutations], CE[@trinhAnalysisFOXO1Mutations]|[Morin et al](papers/morinFrequentMutationHistonemodifying2011)|[@dunsCharacterizationDLBCLPMBL2021b; @schmitzBurkittLymphomaPathogenesis2012]||
42 34
|[GNA13](GNA13)|Tier 1 GE[@morinFrequentMutationHistonemodifying2011], FE[@muppidiLossSignalingGa132014b]|[Morin et al](papers/morinFrequentMutationHistonemodifying2011)|[@loveGeneticLandscapeMutations2012; @reichelFlowSortingExome2015a]||
43
-|[GNAI2](GNAI2)|Tier 1 GE||[@grandeGenomewideDiscoverySomatic2019; @morinMutationalStructuralAnalysis2013]||
44 35
|[HIST1H1B](HIST1H1B)|Tier 1 GE[@krysiakRecurrentSomaticMutations2017b]|[Krysiak et al](papers/krysiakRecurrentSomaticMutations2017b)|[@chapuyMolecularSubtypesDiffuse2018b; @sarkozyMutationalLandscapeGray2021a]||
45 36
|[HIST1H1C](HIST1H1C)|Tier 1 GE[@morinFrequentMutationHistonemodifying2011]|[Morin et al](papers/morinFrequentMutationHistonemodifying2011)|[@paneaWholeGenomeLandscape2019]||
46 37
|[HIST1H1D](HIST1H1D)|Tier 1 GE[@krysiakRecurrentSomaticMutations2017b]|[Krysiak et al](papers/krysiakRecurrentSomaticMutations2017b)|[@jalladesExomeSequencingIdentifies2017; @morinMutationalStructuralAnalysis2013]||
... ...
@@ -54,26 +45,18 @@ link-citations: true
54 45
|[HIST1H3B](HIST1H3B)|Tier 1 GE||[@lohrDiscoveryPrioritizationSomatic2012a; @reichelFlowSortingExome2015a]||
55 46
|[HIST1H3G](HIST1H3G)|Tier 1 GE[@krysiakRecurrentSomaticMutations2017b]|[Krysiak et al](papers/krysiakRecurrentSomaticMutations2017b)|||
56 47
|[HVCN1](HVCN1)|Tier 1 GE[@krysiakRecurrentSomaticMutations2017b]|[Krysiak et al](papers/krysiakRecurrentSomaticMutations2017b)|[@chapuyMolecularSubtypesDiffuse2018b]||
57
-|[IRF4](IRF4)|Tier 1 GE||[@morinFrequentMutationHistonemodifying2011; @mottokIntegrativeGenomicAnalysis2019b]||
48
+|[IRF4](IRF4)|Tier 1 GE[@drevalGeneticSubdivisionsFollicular2023]|[Dreval et al](papers/drevalGeneticSubdivisionsFollicular2023)|[@morinFrequentMutationHistonemodifying2011; @mottokIntegrativeGenomicAnalysis2019b]||
58 49
|[IRF8](IRF8)|Tier 1 GE[@morinFrequentMutationHistonemodifying2011], FE[@qiuIRF8mutantCellLymphoma2024]|[Morin et al](papers/morinFrequentMutationHistonemodifying2011)|[@mottokIntegrativeGenomicAnalysis2019b; @paneaWholeGenomeLandscape2019]||
59
-|[ITPKB](ITPKB)|Tier 1 GE||[@reichelFlowSortingExome2015a; @schmitzGeneticsPathogenesisDiffuse2018a]||
60
-|[KLF2](KLF2)|Tier 1 GE||[@deschGenotypingCirculatingTumor2020; @jalladesExomeSequencingIdentifies2017; @pasqualucciAnalysisCodingGenome2011]||
61 50
|[KLHL6](KLHL6)|Tier 1 GE[@morinFrequentMutationHistonemodifying2011], FE[@merirantaDisruptionKLHL6Fuels2024]|[Morin et al](papers/morinFrequentMutationHistonemodifying2011)|[@ganapathiGeneticLandscapeDural2016]||
62 51
|[KMT2D](KMT2D)|Tier 1 GE[@morinFrequentMutationHistonemodifying2011], FE[@liLossCREBBPKMT2D2024], CE[@rushtonGeneticEvolutionaryPatterns2020]|[Morin et al](papers/morinFrequentMutationHistonemodifying2011)|[@beaLandscapeSomaticMutations2013; @deschGenotypingCirculatingTumor2020; @grandeGenomewideDiscoverySomatic2019; @rossiCodingGenomeSplenic2012c]||
63
-|[LTB](LTB)|Tier 1 GE||[@chapuyMolecularSubtypesDiffuse2018b; @deschGenotypingCirculatingTumor2020]||
64 52
|[MAP2K1](MAP2K1)|Tier 1 GE[@louissaintPediatrictypeNodalFollicular2016a]|[Louissaint et al](papers/louissaintPediatrictypeNodalFollicular2016a)|[@shinBRAFV600EMAP2K12015]||
65 53
|[MEF2B](MEF2B)|Tier 1 GE[@morinFrequentMutationHistonemodifying2011], FE[@yingMEF2BMutationsLead]|[Morin et al](papers/morinFrequentMutationHistonemodifying2011)|[@beaLandscapeSomaticMutations2013]||
66
-|[MEF2C](MEF2C)|Tier 1 GE, FE[@jingjingNovelMEF2CMutation2020]||[@arthurGenomewideDiscoverySomatic2018]||
67
-|[PCLO](PCLO)|Tier 1 GE||[@lohrDiscoveryPrioritizationSomatic2012a]||
68
-|[PIM1](PIM1)|Tier 1 GE, CE[@guoSGK1MutationStatus2022b]||[@burkhardtClinicalRelevanceMolecular2022b; @dunsCharacterizationDLBCLPMBL2021b; @pasqualucciHypermutationMultipleProtooncogenes2001a]||
54
+|[PIM1](PIM1)|Tier 1 GE[@drevalGeneticSubdivisionsFollicular2023], CE[@guoSGK1MutationStatus2022b]|[Dreval et al](papers/drevalGeneticSubdivisionsFollicular2023)|[@burkhardtClinicalRelevanceMolecular2022b; @dunsCharacterizationDLBCLPMBL2021b; @pasqualucciHypermutationMultipleProtooncogenes2001a]||
69 55
|[POU2AF1](POU2AF1)|Tier 1 GE[@krysiakRecurrentSomaticMutations2017b]|[Krysiak et al](papers/krysiakRecurrentSomaticMutations2017b)|[@chapuyMolecularSubtypesDiffuse2018b]||
70 56
|[POU2F2](POU2F2)|Tier 1 GE[@krysiakRecurrentSomaticMutations2017b], FE[@hodsonRegulationNormalBcell2016a]|[Krysiak et al](papers/krysiakRecurrentSomaticMutations2017b)|[@lohrDiscoveryPrioritizationSomatic2012a]||
71
-|[PTPRD](PTPRD)|Tier 1 GE||[@spinaGeneticsNodalMarginal2016b]||
72
-|[RRAGC](RRAGC)|Tier 1 GE, FE[@ortega-molinaOncogenicRagGTPase2019b]||[@okosunRecurrentMTORC1activatingRRAGC2016a]||
73
-|[S1PR2](S1PR2)|Tier 1 GE, FE[@floriHematopoieticOncoproteinFOXP12016]||[@morinFrequentMutationHistonemodifying2011; @muppidiLossSignalingGa132014b]||
57
+|[RRAGC](RRAGC)|Tier 1 GE[@okosunRecurrentMTORC1activatingRRAGC2016a], FE[@ortega-molinaOncogenicRagGTPase2019b]|[Okosun et al](papers/okosunRecurrentMTORC1activatingRRAGC2016a)|||
74 58
|[SGK1](SGK1)|Tier 1 GE[@morinFrequentMutationHistonemodifying2011], FE[@hartmannHighlyRecurrentMutations2016b], CE[@guoSGK1MutationStatus2022b]|[Morin et al](papers/morinFrequentMutationHistonemodifying2011)|[@dunsCharacterizationDLBCLPMBL2021b]||
75 59
|[SMARCA4](SMARCA4)|Tier 1 GE[@krysiakRecurrentSomaticMutations2017b], FE[@dengSMARCA4HaploinsufficientCell2024]|[Krysiak et al](papers/krysiakRecurrentSomaticMutations2017b)|[@nadeuGenomicEpigenomicInsights2020b; @reddyGeneticFunctionalDrivers2017; @richterRecurrentMutationID32012a]||
76
-|[SOCS1](SOCS1)|Tier 1 GE, FE[@melznerBiallelicMutationSOCS12005a]||[@morinFrequentMutationHistonemodifying2011; @wenigerMutationsTumorSuppressor2006a]||
77 60
|[STAT6](STAT6)|Tier 1 GE[@yildizActivatingSTAT6Mutations2015c], FE[@yildizActivatingSTAT6Mutations2015c]|[Yildiz et al](papers/yildizActivatingSTAT6Mutations2015c)|[@ritzRecurrentMutationsSTAT62009a]||
78 61
|[TBL1XR1](TBL1XR1)|Tier 1 GE, FE[@venturuttiTBL1XR1MutationsDrive2020b]||[@lohrDiscoveryPrioritizationSomatic2012a; @rossiCodingGenomeSplenic2012c]||
79 62
|[TMSB4X](TMSB4X)|Tier 1 GE||[@zhangGeneticHeterogeneityDiffuse2013]||
... ...
@@ -84,16 +67,21 @@ link-citations: true
84 67
85 68
## Tier 2 FL genes
86 69
87
-### *49 total*
70
+### *64 total*
88 71
89 72
|Gene|Summary| First FL study | Other entities | QC result |
90 73
|:-:|:-:|:-:|:-|:-|
91 74
|[ABL2](ABL2)|Tier 2 GE[@russler-germainMutationsAssociatedProgression2023b]|[Russler et al](papers/russler-germainMutationsAssociatedProgression2023b)|||
75
+|[ACTB](ACTB)|Tier 2 GE[@drevalGeneticSubdivisionsFollicular2023]|[Dreval et al](papers/drevalGeneticSubdivisionsFollicular2023)|[@lohrDiscoveryPrioritizationSomatic2012a; @wienandGenomicAnalysesFlowsorted2019b]||
92 76
|[ACTG1](ACTG1)|Tier 2 GE[@hubschmannMutationalMechanismsShaping2021b]|[Hubschmann et al](papers/hubschmannMutationalMechanismsShaping2021b)|[@deschGenotypingCirculatingTumor2020; @spinaGeneticsNodalMarginal2016b]||
93 77
|[ATP6V1A](ATP6V1A)|Tier 2 GE[@hubschmannMutationalMechanismsShaping2021b]|[Hubschmann et al](papers/hubschmannMutationalMechanismsShaping2021b)|||
94 78
|[BCL10](BCL10)|Tier 2 GE[@russler-germainMutationsAssociatedProgression2023b], FE[@xiaBCL10MutationsDefine2022]|[Russler et al](papers/russler-germainMutationsAssociatedProgression2023b)|[@morinFrequentMutationHistonemodifying2011; @spinaGeneticsNodalMarginal2016b]||
79
+|[BCL6](BCL6)|Tier 2 GE[@drevalGeneticSubdivisionsFollicular2023], FE[@balSuperenhancerHypermutationAlters2022]|[Dreval et al](papers/drevalGeneticSubdivisionsFollicular2023)|[@loveGeneticLandscapeMutations2012; @morinFrequentMutationHistonemodifying2011]||
80
+|[BIRC6](BIRC6)|Tier 2 GE||[@reddyGeneticFunctionalDrivers2017; @sarkozyMutationalLandscapeGray2021a]||
81
+|[BTG1](BTG1)|Tier 2 GE[@drevalGeneticSubdivisionsFollicular2023], FE[@mlynarczykBTG1MutationYields2023b]|[Dreval et al](papers/drevalGeneticSubdivisionsFollicular2023)|[@burkhardtClinicalRelevanceMolecular2022b; @morinFrequentMutationHistonemodifying2011; @sarkozyMutationalLandscapeGray2021a]||
82
+|[BTG2](BTG2)|Tier 2 GE[@drevalGeneticSubdivisionsFollicular2023], CE[@guoMutationBTG2Gene2022b]|[Dreval et al](papers/drevalGeneticSubdivisionsFollicular2023)|[@loveGeneticLandscapeMutations2012; @morinFrequentMutationHistonemodifying2011]||
95 83
|[CD70](CD70)|Tier 2 GE[@russler-germainMutationsAssociatedProgression2023b]|[Russler et al](papers/russler-germainMutationsAssociatedProgression2023b)|[@morinFrequentMutationHistonemodifying2011]||
96
-|[CD79B](CD79B)|Tier 2 GE, FE[@davisChronicActiveBcellreceptor2010]||[@morinFrequentMutationHistonemodifying2011; @paneaWholeGenomeLandscape2019]||
84
+|[CD79B](CD79B)|Tier 2 GE[@drevalGeneticSubdivisionsFollicular2023], FE[@davisChronicActiveBcellreceptor2010]|[Dreval et al](papers/drevalGeneticSubdivisionsFollicular2023)|[@morinFrequentMutationHistonemodifying2011; @paneaWholeGenomeLandscape2019]||
97 85
|[CDC42BPB](CDC42BPB)|Tier 2 GE[@hubschmannMutationalMechanismsShaping2021b]|[Hubschmann et al](papers/hubschmannMutationalMechanismsShaping2021b)|[@spinaGeneticsNodalMarginal2016b]||
98 86
|[CILP](CILP)|Tier 2 GE[@russler-germainMutationsAssociatedProgression2023b]|[Russler et al](papers/russler-germainMutationsAssociatedProgression2023b)|||
99 87
|[CPNE8](CPNE8)|Tier 2 GE[@hubschmannMutationalMechanismsShaping2021b]|[Hubschmann et al](papers/hubschmannMutationalMechanismsShaping2021b)|||
... ...
@@ -101,35 +89,45 @@ link-citations: true
101 89
|[CYP2A6](CYP2A6)|Tier 2 GE[@russler-germainMutationsAssociatedProgression2023b]|[Russler et al](papers/russler-germainMutationsAssociatedProgression2023b)|||
102 90
|[DDX3X](DDX3X)|Tier 2 GE, FE[@gongSequentialInverseDysregulation2021], CE[@kizhakeyilDDX3XLossAdverse2021]||[@mottokIntegrativeGenomicAnalysis2019b; @reddyGeneticFunctionalDrivers2017; @schmitzBurkittLymphomaPathogenesis2012]||
103 91
|[DHX15](DHX15)|Tier 2 GE[@hubschmannMutationalMechanismsShaping2021b]|[Hubschmann et al](papers/hubschmannMutationalMechanismsShaping2021b)|||
104
-|[DUSP2](DUSP2)|Tier 2 GE||[@dunsCharacterizationDLBCLPMBL2021b; @lohrDiscoveryPrioritizationSomatic2012a]||
92
+|[DTX1](DTX1)|Tier 2 GE, FE[@demirandaExomeSequencingReveals2014], CE[@merirantaDeltex1MutationsPredict2017b]||[@gomezUltraDeepSequencingReveals2023; @loveGeneticLandscapeMutations2012; @rossiCodingGenomeSplenic2012c; @zhangGeneticHeterogeneityDiffuse2013]||
93
+|[DUSP2](DUSP2)|Tier 2 GE[@drevalGeneticSubdivisionsFollicular2023]|[Dreval et al](papers/drevalGeneticSubdivisionsFollicular2023)|[@dunsCharacterizationDLBCLPMBL2021b; @lohrDiscoveryPrioritizationSomatic2012a]||
94
+|[EBF1](EBF1)|Tier 2 GE||[@bohleRoleEarlyBcell2013; @reichelFlowSortingExome2015a; @thomasGeneticSubgroupsInform2023]||
105 95
|[EGR1](EGR1)|Tier 2 GE[@krysiakRecurrentSomaticMutations2017b]|[Krysiak et al](papers/krysiakRecurrentSomaticMutations2017b)|[@reichelFlowSortingExome2015a; @rossiCodingGenomeSplenic2012c]||
96
+|[FAS](FAS)|Tier 2 GE, FE[@seebergerLossFasCD952001]||[@schollMutationsRegionFAS2007; @spinaGeneticsNodalMarginal2016b]||
106 97
|[FZR1](FZR1)|Tier 2 GE[@hubschmannMutationalMechanismsShaping2021b]|[Hubschmann et al](papers/hubschmannMutationalMechanismsShaping2021b)|||
107 98
|[GBP7](GBP7)|Tier 2 GE[@russler-germainMutationsAssociatedProgression2023b]|[Russler et al](papers/russler-germainMutationsAssociatedProgression2023b)|||
99
+|[GNAI2](GNAI2)|Tier 2 GE||[@grandeGenomewideDiscoverySomatic2019; @morinMutationalStructuralAnalysis2013]||
108 100
|[GRM6](GRM6)|Tier 2 GE[@russler-germainMutationsAssociatedProgression2023b]|[Russler et al](papers/russler-germainMutationsAssociatedProgression2023b)|||
109 101
|[HIST1H2BM](HIST1H2BM)|Tier 2 GE[@krysiakRecurrentSomaticMutations2017b]|[Krysiak et al](papers/krysiakRecurrentSomaticMutations2017b)|||
110 102
|[HIST1H3I](HIST1H3I)|Tier 2 GE[@krysiakRecurrentSomaticMutations2017b]|[Krysiak et al](papers/krysiakRecurrentSomaticMutations2017b)|[@paneaWholeGenomeLandscape2019]||
111 103
|[HLA-B](HLA-B)|Tier 2 GE||[@lohrDiscoveryPrioritizationSomatic2012a; @wienandGenomicAnalysesFlowsorted2019b]||
112
-|[HNRNPD](HNRNPD)|Tier 2 GE||[@reddyGeneticFunctionalDrivers2017]||
113 104
|[IGLL5](IGLL5)|Tier 2 GE[@russler-germainMutationsAssociatedProgression2023b]|[Russler et al](papers/russler-germainMutationsAssociatedProgression2023b)|[@chapuyMolecularSubtypesDiffuse2018b; @deschGenotypingCirculatingTumor2020; @paneaWholeGenomeLandscape2019]||
105
+|[ITPKB](ITPKB)|Tier 2 GE[@drevalGeneticSubdivisionsFollicular2023]|[Dreval et al](papers/drevalGeneticSubdivisionsFollicular2023)|[@reichelFlowSortingExome2015a; @schmitzGeneticsPathogenesisDiffuse2018a]||
114 106
|[JUP](JUP)|Tier 2 GE[@hubschmannMutationalMechanismsShaping2021b]|[Hubschmann et al](papers/hubschmannMutationalMechanismsShaping2021b)|||
115 107
|[KIR3DL1](KIR3DL1)|Tier 2 GE[@russler-germainMutationsAssociatedProgression2023b]|[Russler et al](papers/russler-germainMutationsAssociatedProgression2023b)|||
108
+|[KLF2](KLF2)|Tier 2 GE[@drevalGeneticSubdivisionsFollicular2023]|[Dreval et al](papers/drevalGeneticSubdivisionsFollicular2023)|[@deschGenotypingCirculatingTumor2020; @jalladesExomeSequencingIdentifies2017; @pasqualucciAnalysisCodingGenome2011]||
116 109
|[LAPTM5](LAPTM5)|Tier 2 GE[@hubschmannMutationalMechanismsShaping2021b]|[Hubschmann et al](papers/hubschmannMutationalMechanismsShaping2021b)|||
110
+|[LTB](LTB)|Tier 2 GE[@drevalGeneticSubdivisionsFollicular2023]|[Dreval et al](papers/drevalGeneticSubdivisionsFollicular2023)|[@chapuyMolecularSubtypesDiffuse2018b; @deschGenotypingCirculatingTumor2020]||
117 111
|[MAGEC1](MAGEC1)|Tier 2 GE[@russler-germainMutationsAssociatedProgression2023b]|[Russler et al](papers/russler-germainMutationsAssociatedProgression2023b)|||
118 112
|[MAP7D1](MAP7D1)|Tier 2 GE[@russler-germainMutationsAssociatedProgression2023b]|[Russler et al](papers/russler-germainMutationsAssociatedProgression2023b)|||
113
+|[MEF2C](MEF2C)|Tier 2 GE, FE[@jingjingNovelMEF2CMutation2020]||[@arthurGenomewideDiscoverySomatic2018]||
119 114
|[MGEA5](MGEA5)|Tier 2 GE[@hubschmannMutationalMechanismsShaping2021b]|[Hubschmann et al](papers/hubschmannMutationalMechanismsShaping2021b)|||
120 115
|[MKI67](MKI67)|Tier 2 GE[@russler-germainMutationsAssociatedProgression2023b]|[Russler et al](papers/russler-germainMutationsAssociatedProgression2023b)|[@schmitzBurkittLymphomaPathogenesis2012]||
121 116
|[MYC](MYC)|Tier 2 GE, FE[@giallongoIdentificationCmycOncogene1983], CE[@christieCMYCTranslocation142008]||[@dunsCharacterizationDLBCLPMBL2021b; @jalladesExomeSequencingIdentifies2017; @johnstonCmycHypermutationBurkitt1992; @pasqualucciHypermutationMultipleProtooncogenes2001a]||
122 117
|[MYCBP2](MYCBP2)|Tier 2 GE[@hubschmannMutationalMechanismsShaping2021b]|[Hubschmann et al](papers/hubschmannMutationalMechanismsShaping2021b)|||
123
-|[MYD88](MYD88)|Tier 2 GE, FE[@ngoOncogenicallyActiveMYD882011a], CE[@guoSGK1MutationStatus2022b]||[@ngoOncogenicallyActiveMYD882011a; @yanBCRTLRSignaling2012a]||
118
+|[MYD88](MYD88)|Tier 2 GE[@drevalGeneticSubdivisionsFollicular2023], FE[@ngoOncogenicallyActiveMYD882011a], CE[@guoSGK1MutationStatus2022b]|[Dreval et al](papers/drevalGeneticSubdivisionsFollicular2023)|[@ngoOncogenicallyActiveMYD882011a; @yanBCRTLRSignaling2012a]||
124 119
|[NFKBIA](NFKBIA)|Tier 2 GE[@russler-germainMutationsAssociatedProgression2023b]|[Russler et al](papers/russler-germainMutationsAssociatedProgression2023b)|[@thomasMutationalAnalysisIkappaBalpha2004; @wienandGenomicAnalysesFlowsorted2019b]||
125 120
|[OR8H2](OR8H2)|Tier 2 GE[@russler-germainMutationsAssociatedProgression2023b]|[Russler et al](papers/russler-germainMutationsAssociatedProgression2023b)|||
126
-|[P2RY8](P2RY8)|Tier 2 GE, FE[@muppidiLossSignalingGa132014b]||[@lohrDiscoveryPrioritizationSomatic2012a; @muppidiLossSignalingGa132014b]||
121
+|[P2RY8](P2RY8)|Tier 2 GE[@drevalGeneticSubdivisionsFollicular2023], FE[@muppidiLossSignalingGa132014b]|[Dreval et al](papers/drevalGeneticSubdivisionsFollicular2023)|[@lohrDiscoveryPrioritizationSomatic2012a; @muppidiLossSignalingGa132014b]||
127 122
|[PDS5B](PDS5B)|Tier 2 GE[@hubschmannMutationalMechanismsShaping2021b]|[Hubschmann et al](papers/hubschmannMutationalMechanismsShaping2021b)|[@morinMutationalStructuralAnalysis2013]||
128 123
|[PPP4C](PPP4C)|Tier 2 GE[@hubschmannMutationalMechanismsShaping2021b]|[Hubschmann et al](papers/hubschmannMutationalMechanismsShaping2021b)|||
129 124
|[PRKDC](PRKDC)|Tier 2 GE[@hubschmannMutationalMechanismsShaping2021b]|[Hubschmann et al](papers/hubschmannMutationalMechanismsShaping2021b)|[@schmitzGeneticsPathogenesisDiffuse2018a]||
125
+|[PTPRD](PTPRD)|Tier 2 GE[@drevalGeneticSubdivisionsFollicular2023]|[Dreval et al](papers/drevalGeneticSubdivisionsFollicular2023)|[@spinaGeneticsNodalMarginal2016b]||
130 126
|[PZP](PZP)|Tier 2 GE[@russler-germainMutationsAssociatedProgression2023b]|[Russler et al](papers/russler-germainMutationsAssociatedProgression2023b)|||
131 127
|[RBM6](RBM6)|Tier 2 GE[@hubschmannMutationalMechanismsShaping2021b]|[Hubschmann et al](papers/hubschmannMutationalMechanismsShaping2021b)|||
128
+|[S1PR2](S1PR2)|Tier 2 GE[@drevalGeneticSubdivisionsFollicular2023], FE[@floriHematopoieticOncoproteinFOXP12016]|[Dreval et al](papers/drevalGeneticSubdivisionsFollicular2023)|[@morinFrequentMutationHistonemodifying2011; @muppidiLossSignalingGa132014b]||
132 129
|[SHROOM3](SHROOM3)|Tier 2 GE[@russler-germainMutationsAssociatedProgression2023b]|[Russler et al](papers/russler-germainMutationsAssociatedProgression2023b)|||
130
+|[SOCS1](SOCS1)|Tier 2 GE[@drevalGeneticSubdivisionsFollicular2023], FE[@melznerBiallelicMutationSOCS12005a]|[Dreval et al](papers/drevalGeneticSubdivisionsFollicular2023)|[@morinFrequentMutationHistonemodifying2011; @wenigerMutationsTumorSuppressor2006a]||
133 131
|[SRRM2](SRRM2)|Tier 2 GE[@russler-germainMutationsAssociatedProgression2023b]|[Russler et al](papers/russler-germainMutationsAssociatedProgression2023b)|[@morinMutationalStructuralAnalysis2013]||
134 132
|[STAB2](STAB2)|Tier 2 GE[@russler-germainMutationsAssociatedProgression2023b]|[Russler et al](papers/russler-germainMutationsAssociatedProgression2023b)|||
135 133
|[TMEM30A](TMEM30A)|Tier 2 GE[@morinFrequentMutationHistonemodifying2011], FE[@ennishiTMEM30ALossoffunctionMutations2020b], CE[@ennishiTMEM30ALossoffunctionMutations2020b]|[Morin et al](papers/morinFrequentMutationHistonemodifying2011)|||